Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
Screening for breast cancer improves early detection of aggressive cancers and has been shown to reduce breast cancer related mortality. Currently, mammography is the most effective way of detecting early stage, non palpable breast cancers. However, mammography only reveals the breast structure, and cannot say much about the breast physiological state. We propose Tomographic Optical Breast Imaging (TOBI) as an inexpensive, patient friendly technique that is non-invasive and does not use non-ionizing radiation. TOBI uses near infrared light and by measuring how such light passes through the breast, images of blood volume and hemoglobin oxygenation can be obtained. In this study, TOBI is combined with digital breast tomosynthesis (DBT, a form of 3D mammography) and our hypothesis is that the TOBI-DBT combined images can be used to diagnose breast cancer with significantly improved sensitivity and specificity compared to DBT alone.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Any adult female volunteers of any race or ethnic background, between the ages of 30 to 80, either
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
375 participants in 1 patient group
Loading...
Central trial contact
Mansi Saksena, MBBS; Stefan Carp, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal